Stefanutti, C., Blom, D., Averna, M., Meagher, E., Theron, H., Marais, A., . . . Cuchel, M. (2015). The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – a post-hoc analysis of a Phase 3, single-arm, open-label trial. Atherosclerosis.
Παραπομπή Chicago StyleStefanutti, C., et al. "The Lipid-lowering Effects of Lomitapide Are Unaffected By Adjunctive Apheresis in Patients With Homozygous Familial Hypercholesterolaemia – a Post-hoc Analysis of a Phase 3, Single-arm, Open-label Trial." Atherosclerosis 2015.
Παραπομπή MLAStefanutti, C., et al. "The Lipid-lowering Effects of Lomitapide Are Unaffected By Adjunctive Apheresis in Patients With Homozygous Familial Hypercholesterolaemia – a Post-hoc Analysis of a Phase 3, Single-arm, Open-label Trial." Atherosclerosis 2015.